ALIM Shares Outstanding History
Below is a table of the ALIM shares outstanding history going back to 4/22/2010:

Date ALIM Shares Outstanding
4/22/20102.03M
6/1/20102.07M
8/10/20102.08M
11/5/20102.08M
5/4/20112.09M
8/3/20112.09M
11/3/20112.10M
12/31/20112.10M
5/9/20122.10M
8/8/20122.10M
11/2/20122.10M
3/26/20132.10M
5/7/20132.10M
8/8/20132.11M
11/8/20132.11M
2/28/20142.53M
5/7/20142.69M
8/7/20142.69M
11/12/20142.95M
3/6/20152.96M
5/8/20152.96M
8/7/20152.96M
11/5/20152.97M
3/11/20163.00M
5/4/20163.01M
8/4/20163.05M
11/3/20164.32M
3/1/20174.32M
5/10/20174.33M
8/8/20174.60M
11/2/20174.61M
2/28/20184.67M
5/7/20184.67M
7/31/20184.67M
11/7/20184.67M
2/22/20194.73M
5/6/20194.73M
8/5/20194.73M
3/13/20181.25M
11/4/20194.96M
11/15/20194.96M
2/27/20204.97M
5/4/20205.03M
8/3/20205.03M
10/29/20205.13M
3/1/20215.75M
5/3/20216.92M
8/11/20216.92M
11/2/20216.94M
3/21/20226.99M
4/25/20226.99M
5/10/20227.00M
8/3/20227.00M
11/10/20227.01M

Also see: ALIM Market Cap History
ALIM YTD Return
ALIM Historical Shares Outstanding:
+10.35% CAGR
ALIM Historical Shares Outstanding: +10.35% CAGR

Mouse over chart for data details
4/22/2010 ...11/10/2022
Alimera Sciences is a pharmaceutical company that focuses on the commercialization and development of ophthalmic pharmaceuticals. Co. focuses on diseases affecting the retina. Co.'s commercial product is ILUVIEN®, an intravitreal implant that treats patients by delivering a continuous microdose of the corticosteroid fluocinolone acetonide in the eye, for up to 36 months. ILUVIEN is also used in certain countries in the European Economic Area to prevent relapse in recurrent non-infectious uveitis affecting the posterior segment of the eye. LUVIEN is inserted into the back of the patient's eye in a non-surgical procedure employing a device with a needle, which allows for a self-sealing wound. We show 54 historical shares outstanding datapoints in our coverage of ALIM's shares outstanding history.

Understanding the changing numbers of ALIM shares outstanding — and comprehending the concept of differing number of shares outstanding in general comparing companies like ALIM versus peers — is critical for investors. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies. Furthermore, via issuance of new shares over time, or the repurchase of existing shares, the number of shares outstanding can fluctuate over the course of history. With this page we aim to empower investors researching ALIM by allowing them to research ALIM shares outstanding history as well as any other stock in our coverage universe.
Quotes delayed 20 minutes

Email EnvelopeFree ALIM Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 ETFs With Stocks That Insiders Are Buying
10 ETFs With Most Upside To Analyst Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Energy Stocks You Can Buy Cheaper Than Insiders Did
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active Call & Put Options of the S&P 500 Components
Video: Shares Outstanding Importance


If the video does not load after a few moments, Upgrade to the Latest Flash Player.
Alimera Sciences (ALIM) is categorized under the Healthcare sector; to help you further research historical shares outstanding numbers, below are some other companies in the same sector:

ALKS Shares Outstanding History
ALLK Shares Outstanding History
ALLO Shares Outstanding History
ALNA Shares Outstanding History
ALNY Shares Outstanding History
ALOG Shares Outstanding History
ALPN Shares Outstanding History
ALQA Shares Outstanding History
ALRN Shares Outstanding History
ALT Shares Outstanding History
More Healthcare companies »

 

ALIM Shares Outstanding History | www.SharesOutstandingHistory.com | Copyright © 2017 - 2022, All Rights Reserved

Nothing in SharesOutstandingHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.